Houston, TX
United States
University of Texas at Houston - Department of Lymphoma and Myeloma
Follicular Lymphoma, B-Cell Lymphoma, Lenalidomide, Therapeutic Use, Obinutuzumab, Antineoplastic Agents, Immunological
Lymphoma, BCL6, epigenetics, plasticity
CAR T-cell, B-cell lymphoma, Cytopenia, Interferon
Hodgkin lymphoma, health disparity, outcomes research